United States
Germany
Japan
United Kingdom
China
Recombinant protein of human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Proteins
IGF1R HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR),residues 1-645aa,expressed in sf9 cells
| Tag | C-His |
| Expression Host | Sf9 |
Transient overexpression lysate of v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
CD332 / FGFR-2 (IIIC - Fc Chimera) human recombinant protein, 10 µg
| Expression Host | Insect |
BRAF HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
EGFR HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
PDPK1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human insulin-like growth factor 1 receptor (IGF1R), residues 741-935aa, with C-terminal DDK tag, expressed in sf9, 20ug
| Tag | C-DDK |
| Expression Host | Sf9 |
CD340 / ERBB2 / HER2 human recombinant protein, 0.1 mg
| Expression Host | E. coli |
AKT3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
IGF1R MS Standard C13 and N15-labeled recombinant protein (NP_000866)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
EGFR / ERBB1 (25-645, hIgG-His tag) human protein, 50 µg
| Tag | hIgG-His-tag |
AKT1 / PKB (1-480, His-tag) human recombinant protein, 0.25 mg
| Tag | His-tag |
B-Raf proto-oncogene (432-766, His-tag) human recombinant protein, 0.5 mg
| Tag | His-tag |
| Expression Host | E. coli |
